Technical Analysis for GENE - Genetic Technologies Ltd

Grade Last Price % Change Price Change
grade C 3.886 2.53% 0.10
GENE closed down 0.52 percent on Wednesday, February 19, 2020, on 3 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical GENE trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 2.53%
Doji - Bearish? Reversal 2.53%
Oversold Stochastic Weakness 1.99%
Bullish Engulfing Bullish 5.03%
Oversold Stochastic Weakness 5.03%
Stochastic Buy Signal Bullish 8.85%
1,2,3 Pullback Bullish Bullish Swing Setup 8.85%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 8.85%
Down 3 Days in a Row Weakness 8.85%
Down 4 Days in a Row Weakness 8.85%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Genetic Technologies Limited provides genetic testing services. It offers a range of DNA based genetic tests for cancer predisposition, including breast cancer, ovarian cancer, bowel cancer, and uterine cancer; neurogenetic diagnostic assays; and gene testing for gene related disorders. The company also provides forensics tests, such as presumptive and confirmatory testing, individual DNA profiling, species identification, and animal forensic testing; paternity tests, which include antenatal, deceased estate, grandparent, immigration, legal paternity, non-legal paternity, sibling, twins, and Y-Chromosome DNA testing, as well as DNA profiling; and personal DNA testing comprising sports performance and ancestry gene testing. In addition, it offers animals' tests consisting of disease testing, breed identification, coat color, and forensic DNA testing, as well as DNA clinical services; and plant tests, including genomic and Xpress sequencing services. Further, the company is involved in the out-licensing of its intellectual property relating to non-coding DNA; and research and development activities in the areas of genetics and related fields. It operates in Australia, the United States, China, Canada, and Switzerland. The company was formerly known as Duketon Goldfields N.L. and changed it name to Genetic Technologies Limited in August 2000 as a result of the change in business from mining to biotechnology. Genetic Technologies Limited is headquartered in Fitzroy, Australia.
Biotechnology Cancer Biology Disease Breast Cancer Genetics Ovarian Cancer Medical Tests Applied Genetics Clinical Services DNA Genetic Testing DNA Paternity Testing

Is GENE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.32
52 Week Low 1.5601
Average Volume 707,079
200-Day Moving Average 2.55
50-Day Moving Average 3.20
20-Day Moving Average 3.95
10-Day Moving Average 3.74
Average True Range 0.31
ADX 43.03
+DI 28.12
-DI 15.36
Chandelier Exit (Long, 3 ATRs ) 3.82
Chandelier Exit (Short, 3 ATRs ) 4.32
Upper Bollinger Band 4.47
Lower Bollinger Band 3.43
Percent B (%b) 0.35
BandWidth 26.45
MACD Line 0.08
MACD Signal Line 0.16
MACD Histogram -0.0824
Fundamentals Value
Market Cap 61.54 Million
Num Shares 16.2 Million
EPS -0.45
Price-to-Earnings (P/E) Ratio -8.42
Price-to-Sales 33.69
Price-to-Book 1.92
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.03
Resistance 3 (R3) 4.06 4.00 3.99
Resistance 2 (R2) 4.00 3.94 3.99 3.98
Resistance 1 (R1) 3.90 3.90 3.87 3.87 3.96
Pivot Point 3.84 3.84 3.83 3.83 3.84
Support 1 (S1) 3.74 3.78 3.71 3.71 3.62
Support 2 (S2) 3.68 3.74 3.67 3.60
Support 3 (S3) 3.58 3.68 3.59
Support 4 (S4) 3.55